Tampa General Hospital Earns Prestigious FACT Accreditation for Cancer Care Excellence and Innovation

Tampa General Hospital Receives FACT Accreditation

Tampa General Hospital (TGH) proudly announces that it, along with the TGH Cancer Institute, has received accreditation from the Foundation for the Accreditation of Cellular Therapy (FACT). This recognition underscores TGH's relentless pursuit of excellence and innovation in cancer care, particularly in the areas of stem cell transplant and cellular therapy.

Receiving FACT accreditation is no small feat. The foundation, a recognized nonprofit, establishes stringent standards to ensure quality and safety in cellular therapies. By meeting these international benchmarks, TGH demonstrates a commitment to the highest patient care practices, including the collection, processing, and administration of cells. The accreditation stands as a mark of quality acknowledged by major organizations such as the U.S. Food and Drug Administration and The Joint Commission.

"We are honored to be recognized by FACT," stated Dr. Eduardo Sotomayor, the executive director of TGH Cancer Institute. He emphasized that as a leading academic health system, the goal is to continually provide transformative treatments to patients. This accreditation is a significant indicator of TGH's efforts in developing a premier cancer institute that serves as a research-driven resource for those battling cancer.

The cellular therapy program at TGH includes advanced treatment options like Chimeric Antigen Receptor (CAR) T-cell therapy and stem cell transplants, specifically designed for patients with aggressive blood cancers such as lymphomas, multiple myeloma, and leukemias. Dr. Ivan Borrello, a physician-scientist and lead medical director for the program, highlighted a focus on innovative immune-based therapies that can change the standard of care for patients with complex cancer types. His background at Johns Hopkins further strengthens the program's initiatives and capabilities.

TGH's cancer care team features dedicated professionals, including specialized nurses, practitioners, and social workers who deliver exemplary care in both inpatient and outpatient settings. According to Dr. Abraham Schwarzberg, TGH’s executive vice president and oncology chief, this accreditation not only reinforces TGH's leadership in cellular therapy but also instills confidence in patients regarding their treatment's quality and compassion.

In terms of recognition, TGH Cancer Institute is among the top 10% of U.S. hospitals as stated by U.S. News & World Report for 2025-2026. Partnering with the USF Health Morsani College of Medicine, the institute offers groundbreaking therapies, advanced diagnostic tools, and coordinated patient care to enhance treatment outcomes. Its excellence is further validated through certifications from the American College of Surgeons and the American Society of Clinical Oncology, confirming adherence to strict quality measures.

Tampa General Hospital operates as the only academic health system in the Tampa Bay area, boasting a 1,529-bed nonprofit institution that offers comprehensive inpatient and outpatient services throughout Florida. It specializes in Level l trauma and burn care, catering to a vast number of residents across 23 counties. Notably, TGH was ranked the highest in Tampa Bay in the U.S. News & World Report for Best Hospitals in 2025-2026, with top rankings in multiple medical specialties.

Furthermore, TGH is known for its pioneering technology, being the first in Florida to employ a clinical command center to enhance real-time patient care. The system leverages artificial intelligence and analytics, ensuring timely and safe treatment for all patients, reinforcing its stance as a leader in innovative healthcare delivery.

In addition to its clinical endeavors, TGH plays a vital role as the area's safety-net hospital, providing care regardless of patients' financial situations, contributing significantly to community health initiatives.

In conclusion, the recognition from FACT represents not just an accolade, but a milestone in TGH's ongoing journey to elevate cancer care, embodying excellence in medical practices and a steadfast commitment to improving patient quality of life in Tampa and beyond.